PYMNTS.com October 29, 2024
Wayne State scientists are developing artificial intelligence models to cut costs in complex drug design, while Stanford research reveals ChatGPT-4 achieving 92% medical diagnostic accuracy — outperforming human doctors scoring 74%. This wave of AI breakthroughs is reflected in financial markets, where health tech stocks rose 12% in 2024 and AI healthcare companies now command valuations up to five times higher than their non-AI counterparts, attracting 38% of venture capital healthcare investments.
AI Models Could Cut Drug Development Costs
A project at Wayne State University aims to harness AI and computer models to design new medications, mainly focusing on complex drug types that have traditionally been difficult to simulate.
“Most drug design is done with small organic molecules,” Alice Walker,...
Today's Sponsors
Today's Sponsor